GlassScriptPhysician profile
Evan Philip Pisick
NPI 1427096700
$569.56
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $50.10 · 2021: $18.84 · 2023: $81.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $114.39 | 2019 | |
| Pfizer INC. | $97.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $87.91 | 2019-2023 | |
| Exelixis INC. | $73.76 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $47.93 | 2019-2020 | |
| Gilead Sciences, INC. | $42.41 | 2023 | Trodelvy |
| Emd Serono, INC. | $35.10 | 2019-2020 | |
| Genentech USA, INC. | $19.58 | 2019 | |
| Glaxosmithkline, LLC. | $18.90 | 2020 | |
| Collegium Pharmaceutical, INC. | $18.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.85 | 2023 | Enhertu |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Pisick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.